Sanofi India Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sanofi India has received an order from the Principal/Joint Commissioner of CGST & Central Excise, Mumbai, dated December 29, 2025. The order covers FY 2018-19 to FY 2022-23 and raises a tax demand of Rs 1.43 crore along with an equal penalty of Rs 1.43 crore, plus applicable interest under the CGST and IGST Act, 2017. The dispute relates to alleged wrong availment and utilization of Input Tax Credit (ITC). The company has stated it will file an appeal before higher tax authorities to contest the order.
The combined demand of about Rs 2.87 crore (tax + penalty) is small relative to Sanofi India's size and is unlikely to materially affect operations or financials, though the final outcome of the appeal will determine actual liability. Shareholders should monitor the appeal process, as an adverse ruling could result in a larger payout including interest.